Page last updated: 2024-10-27

fluoxetine and Neurologic Voice Disorder

fluoxetine has been researched along with Neurologic Voice Disorder in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petitpain, N1
Gambier, N1
Gillet, P1
Muller, JC1
de Romemont, E1
Murray, V1

Other Studies

2 other studies available for fluoxetine and Neurologic Voice Disorder

ArticleYear
Dysphonia induced by selective serotonin reuptake inhibitors.
    Southern medical journal, 2005, Volume: 98, Issue:8

    Topics: Aged; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors;

2005
Laryngeal dystonia.
    The British journal of psychiatry : the journal of mental science, 1995, Volume: 167, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Chlorpromazine; Drug Overdose; Drug Synergism; Dystonia; Ethanol;

1995